News

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com

Trilantic Europe, a leading pan-European private equity firm, announces today that it has completed the sale of the IASO Real Estate Fund (“IASO”) to Colliers Global Investors Italy SGR (“CGI”). CGI has acquired 100% of IASO through the Aesculapius Fund. Its main unitholder is Fondazione ENPAM, the pension fund for Italian doctors and dentists, with €25 billion in assets under management.

IASO owns 11 hospital facilities, 10 of which are leased and operated by ICS Maugeri Spa Società Benefit (“ICSM”), and one by a third party, used as a nursing home. The facilities operated by ICSM include 6 IRCCS Scientific Institutes, best-in-class hospitals of the Italian NHS that pursue research in the biomedical field. Overall, the IASO real estate portfolio comprises 1,200 beds accredited by the Italian NHS in Lombardy, Piemonte, Campania and Puglia.

Trilantic Europe, through TCP Hospitals S.A., originally invested in ICSM alongside Fondazione Salvatore Maugeri (“FSM”). Following an asset swap agreement completed in March 2024, Trilantic Europe became the owner of 100% of IASO by exchanging its participation in ICSM with the majority shareholder, FSM. This transaction enabled FSM to regain full control of ICSM, while providing Trilantic Europe with a liquid asset – IASO – which has now been successfully sold by Trilantic Europe to a strategic investor.

Vittorio Pignatti-Morano, Chairman and Co-Founder at Trilantic Europe: “We are very pleased with our original investment in ICS Maugeri and with the subsequent agreement reached with Fondazione Salvatore Maugeri, which enabled it to regain control of ICSM while allowing Trilantic Europe to successfully monetise its investment through the sale of IASO.” 

Trilantic Europe was advised by law firm ADVANT Nctm, with Mediobanca and Intesa Sanpaolo (IMI CIB Division) acting as financial advisors. Colliers Global Investors Italy SGR was advised by law firm DLA Piper, while YARD REAAS served as advisor for the technical due diligence. IASO was advised by Namira SGR.

Trilantic Europe

Trilantic Europe is an independent private equity investor specializing in mid-market management-led buy-out transactions across Europe. Trilantic Europe is managed by an experienced group of over 30 professionals and 15 operating partners and senior advisors. Trilantic Europe has invested over €2.9 billion in 31 companies since 2004 and it currently manages approximately €2.4 billion in assets from a wide base of investors.

Colliers Global Investors Italy

Colliers Global Investors Italy, previously named “Antirion,” is an independent Italian asset management company (SGR) specializing in the creation and management of closed-end alternative real estate funds for institutional investors. With approximately €5 billion under management in Italy and internationally, they oversee funds like Antirion Æsculapius. This closed-end alternative real estate investment fund targets qualified investors and focuses on healthcare sector properties, including healthcare/functional and hospitality uses. Its current holdings include the “Ospedale San Giuseppe” hospital complex at Via San Vittore 12 in Milan.

Media Contact:

Trilantic Europe

Agnes Riousse, agnes.riousse@cdrconsultancy.com 

Jonah Boon, jonah.boon@cdrconsultancy.com